GoodRx Holdings, Inc. (GDRX)

Market Cap	2.95B
Revenue (ttm)	764.16M
Net Income (ttm)	-6.59M
Shares Out	375.20M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	19.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,086,876
Open	7.53
Previous Close	7.56
Day's Range	7.50 - 7.90
52-Week Range	4.14 - 9.37
Beta	1.38
Analysts	Buy
Price Target	9.16 (+16.39%)
Earnings Date	May 9, 2024

About GDRX

GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves ph...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Sep 23, 2020
• Employees: 694
• Stock Exchange: NASDAQ
• Ticker Symbol: GDRX

Financial Performance

In 2023, GDRX's revenue was $750.27 million, a decrease of -2.12% compared to the previous year's $766.55 million. Losses were -$8.87 million, -72.99% less than in 2022.

Analyst Forecast

According to 19 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price forecast is $9.16, which is an increase of 16.39% from the latest price.

Price Target

$9.16

(16.39% upside)

Analyst Consensus: Buy